November 10
12 min read
In 2024, ASCO updated its guideline for the integration of palliative care in oncology, which recommends that clinicians refer patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams beginning early in the course of a patient’s disease in conjunction with active treatment.1 However, despite ASCO’s recommendations, utilization of palliative care in the oncology setting remains low, with about one-third of patients globally receiving this service, with the highest utilization rate of nearly 56% in Africa and the lowest, 30%, in the United States.2